Mopralpro (Omeprazole Magnesium)

Omeprazole magnesium, the active ingredient in Mopralpro, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease, primarily in adult patients.

GNH USA supplies Mopralpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Omeprazole magnesium is used to treat conditions associated with excess gastric acid production.

- Gastro‑oesophageal reflux disease (GERD): relief of heartburn and prevention of acid‑related esophageal damage. - Erosive esophagitis: promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hypomagnesemia: low magnesium levels causing muscle weakness or arrhythmia. - Elevated liver enzymes: potential hepatic injury. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Interstitial nephritis: inflammation of kidney tissue.

Before initiating therapy, consider the following precautions: - Assess renal function: adjust use in severe renal impairment. - Monitor for infection: be aware of increased risk of Clostridioides difficile colitis. - Review duration of therapy: avoid long‑term use without periodic evaluation due to fracture risk. - Use caution in pregnancy: limited data; discuss benefits and risks with a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Omeprazole magnesium may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atazanavir: decreased antiviral activity. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR and bleeding risk. - Digoxin: possible rise in serum concentration. - Methotrexate: enhanced toxicity, especially at high doses.